The global interventional cardiology devices market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady growth of the interventional cardiology devices market can be attributed to rising incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the US, and is responsible for around 655,000 deaths every year. Coronary heart disease is the leading heart disease type that, in 2017, accounted for the deaths of 365,914 individuals in the US.
The number of people who have cardiovascular and vascular problems has been gradually increasing, and the elderly population is expanding. As a result, there is now more need for medical equipment used to treat cardiovascular and vascular diseases. A range of heart and artery disorders can also be treated using peripheral vascular devices and interventional cardiology. Additionally, the market shares for peripheral vascular and interventional cardiology devices have benefited from technical advancements. Additionally, the rapidly rising healthcare industry in emerging countries has a beneficial influence on the market growth for peripheral vascular and interventional cardiology equipment.
Key interventional cardiology devices market participants include Abbott Laboratories, Terumo Corporation, iVascular, Boston Scientific Corporation, Edwards Lifesciences Corporation, B.Braun Melsungen, Medtronic PLC, Koninklijke Philips NV, Biosensors International Group Ltd., and Endocor GmbH.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the Interventional Cardiology Devices Market. Also, to arrive at an accurate and unbiased market forecast, data collected from secondary research sources have been analyzed and validated through primaries.
Get free copy of the interventional cardiology devices market report 2022: https://www.emergenresearch.com/request-sample/570
The research report on the Global interventional cardiology devices market is formulated with insightful data that will help the established companies and new entrants to analyze the business trends and capitalize on investment strategies. The interventional cardiology devices market is analyzed with an aim to provide assistance to the readers to gain maximum returns on the investment and to enable an informed decision-making process.
Key inclusions of the interventional cardiology devices market report:
COVID-19 effects on growth figures.
Statistical analysis pertaining to market size, sales volume, and overall industry revenue.
Organized mentions of major market trends.
Growth opportunities.
Figures showcasing market growth rate.
Advantages and disadvantages of direct and indirect sales channels.
Insights regarding traders, distributors, and dealers present in the industry.
Some Key Highlights from the Report :
In June 2019, Terumo Corporation signed a partnership agreement with Orchestra BioMed, Inc. This partnership provides Terumo Corporation with exclusive rights for the development and marketing of Virtue Sirolimus-Eluting Balloon (SEB).
Angioplasty stents find application to restore blood flow occurring due to blockage and to reduce heart attack risk. Stents are considered beneficial in reducing damage caused to heart muscles in the event of a heart attack. Also, stents may instantly relieve or reduce symptoms comprising chest pain, fatigue, and shortness of breath.
The hospitals end-use segment had the highest revenue share among the end-use segments in 2020, which can be attributed to the region’s high purchasing power for advanced and specialised interventional cardiology devices as well as the region’s strong presence of skilled medical professionals for installing interventional cardiology devices and more developed healthcare infrastructure. Hospitals also take into account the patient’s adverse event minimization during important treatments like cardiac catheterization and stent implantation.
Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.emergenresearch.com/industry-report/interventional-cardiology-devices-market
Emergen Research has segmented the global interventional cardiology devices market on the basis of product type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Angioplasty Stents
Angioplasty Balloons
Catheters
Structural Heart Devices
Plaque Modification Devices
Guidewires
Hemodynamic Flow Alteration Devices
Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Ambulatory Surgical Centers
Others
!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted Price@ https://www.emergenresearch.com/request-discount/570
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
What market dynamics does this report cover?
The report shares key insights on:
- Current market size
- Market forecast
- Market opportunities
- Key drivers and restraints
- Regulatory scenario
- Industry trend
- New product approvals/launch
- Promotion and marketing initiatives
- Pricing analysis
- Competitive landscape
Some of the key questions answered in this report:
Which are the fastest growing countries in terms of the global Unmanned underwater vehicles Market ?
What are the key strategies being adopted by market players in the global Unmanned underwater vehicles Market ?
Which are the emerging companies in the global Unmanned underwater vehicles Market ?
How has COVID-19 impacted the growth of the global Unmanned underwater vehicles Market ?
What are the key regulations governing the Unmanned underwater vehicles Market in key regions?
TO Check Our Other Blogs @
Synthetic Blood Substitutes Market
About Emergen Research
Emergen Research is a Market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer Market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Reports: Botulinum Toxin Market | Dermocosmetics Market
Trending Titles: ai in healthcare market | in-vehicle infotainment market
Thank you for reading our report. Customization of the report is available according to the requirements of clients. Kindly get in touch with us to know more about the report.